Anne McGeorge Insider Profile
11 Followers
Anne McGeorge, Director at Dianthus Therapeutics, holds 0.00 shares in Dianthus Therapeutics (Ticker: DNTH), holds 332.54K shares in Starling Oncology Institute (Ticker: STLN), holds 0.00 shares in SOC Telemed (Ticker: TLMD).
Anne McGeorge has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Anne McGeorge holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Anne McGeorge
Anne McGeorge's Trading History
Dianthus Therapeutics
Aug 11, 2026
Director
Uninformative Buy
97.00K
$0.00
SOC Telemed
Apr 07, 2022
―
Uninformative Sell
175.16K
$0.00
Starling Oncology Institute
Jul 29, 2026
Director
Uninformative Buy
―
$2.10M
List of latest transactions for each holding click on a transaction to see Anne McGeorge's performance on stock
You May Also Like
Anne McGeorge insider profile FAQ
What is the percentage of profitable transactions made by Anne McGeorge?
The percentage of profitable transactions made by Anne McGeorge is ―.
What is the average return per transaction made by Anne McGeorge?
The average return per transaction made by Anne McGeorge is ―.
What stocks does Anne McGeorge hold?
Anne McGeorge holds: DNTH, TLMD, STLN stocks.
What was Anne McGeorge’s latest transaction?
Anne McGeorge latest transaction was an Uninformative Buy of $97.00K.
What was Anne McGeorge's most profitable transaction?
Anne McGeorge’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Anne McGeorge's role in Dianthus Therapeutics?
Anne McGeorge's role in Dianthus Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.